240 related articles for article (PubMed ID: 27011176)
41. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
42. Integrin targeted drug and gene delivery.
Wang Z; Chui WK; Ho PC
Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
[TBL] [Abstract][Full Text] [Related]
43. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
44. Skeletal function and structure: implications for tissue-targeted therapeutics.
Shea JE; Miller SC
Adv Drug Deliv Rev; 2005 May; 57(7):945-57. PubMed ID: 15876397
[TBL] [Abstract][Full Text] [Related]
45. [Improved Therapeutic Efficacy in Bone and Joint Disorders by Targeted Drug Delivery to Bone].
Takahashi T
Yakugaku Zasshi; 2016; 136(11):1501-1508. PubMed ID: 27803481
[TBL] [Abstract][Full Text] [Related]
46. In vivo targeted delivery of nanoparticles for theranosis.
Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.
Wang D; Sima M; Mosley RL; Davda JP; Tietze N; Miller SC; Gwilt PR; Kopecková P; Kopecek J
Mol Pharm; 2006; 3(6):717-25. PubMed ID: 17140259
[TBL] [Abstract][Full Text] [Related]
48. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
Kouchakzadeh H; Safavi MS; Shojaosadati SA
Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
[TBL] [Abstract][Full Text] [Related]
49. [New therapeutic targets for osteoporosis].
Orcel P
Rev Prat; 2012 Feb; 62(2):214-5. PubMed ID: 22408866
[No Abstract] [Full Text] [Related]
50. Targeting sclerostin as potential treatment of osteoporosis.
Papapoulos SE
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
[TBL] [Abstract][Full Text] [Related]
51. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
52. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy.
Saad F; Sternberg CN
Nat Clin Pract Urol; 2007 Feb; 4 Suppl 1():S3-13. PubMed ID: 17264863
[TBL] [Abstract][Full Text] [Related]
53. Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents.
Poon M; Zeng L; Zhang L; Hsiao J; Wong E; Lam H; Bedard G; Chow E
J Comp Eff Res; 2013 Jan; 2(1):69-76. PubMed ID: 24236523
[TBL] [Abstract][Full Text] [Related]
54. Nanotechnology controlled drug delivery for treating bone diseases.
Yang L; Webster TJ
Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
[TBL] [Abstract][Full Text] [Related]
55. Bone-targeting macromolecular therapeutics.
Wang D; Miller SC; Kopecková P; Kopecek J
Adv Drug Deliv Rev; 2005 May; 57(7):1049-76. PubMed ID: 15876403
[TBL] [Abstract][Full Text] [Related]
56. [The use of bisphosphonates for treating pathological states in orthopedics].
Białecki P; Bohatyrewicz A; Machoy-Mokrzyńska A; Białecka M
Chir Narzadow Ruchu Ortop Pol; 2008; 73(4):266-73. PubMed ID: 18847019
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D for your patients with chronic hepatitis C?
Rahman AH; Branch AD
J Hepatol; 2013 Jan; 58(1):184-9. PubMed ID: 22871501
[TBL] [Abstract][Full Text] [Related]
58. Clodronate in the prevention and treatment of skeletal metastasis.
Gulley J; Dahut WL
Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
[TBL] [Abstract][Full Text] [Related]
59. Overcoming in vivo barriers to targeted nanodelivery.
Chrastina A; Massey KA; Schnitzer JE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
[TBL] [Abstract][Full Text] [Related]
60. An in vitro assay to measure targeted drug delivery to bone mineral.
Jahnke W; Henry C
ChemMedChem; 2010 May; 5(5):770-6. PubMed ID: 20209564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
